{
    "prefix": "Approach the following multiple choice question the way a medical researcher would. ",
    "problem_prompt": "Approach the following multiple choice question the way a medical researcher would. Infertility issues with leiomyoma can be addressed by\n1: Combined oral contraceptive pills\n2: DMPA\n3: GnRH agonist\n4: Ulipristal",
    "solution": 3,
    "gpt_response": "In order to address infertility issues related to leiomyoma, a medical researcher would consider the mechanism of action of each of the options provided in the multiple choice question:\n\n1: Combined oral contraceptive pills - While oral contraceptive pills may help manage symptoms of leiomyoma, they are not typically used to address infertility issues related to this condition.\n\n2: DMPA (depot medroxyprogesterone acetate) - DMPA is a progestin-only contraceptive injection that is not typically used to address infertility issues related to leiomyoma.\n\n3: GnRH agonist (gonadotropin-releasing hormone agonist) - GnRH agonists are often used to shrink leiomyoma and may be considered in the management of infertility issues associated with this condition.\n\n4: Ulipristal - Ulipristal is a selective progesterone receptor modulator that has been used in the treatment of symptomatic leiomyoma, but its role in addressing infertility issues related to this condition is less clear.\n\nBased on the above information, a medical researcher would likely choose option 3: GnRH agonist as the most appropriate option for addressing infertility issues with leiomyoma.",
    "solution_prompt": "The following is a response to a question, with options 1, 2, 3, 4. Yes or no, is the final solution obtained in the following response 3?: In order to address infertility issues related to leiomyoma, a medical researcher would consider the mechanism of action of each of the options provided in the multiple choice question:\n\n1: Combined oral contraceptive pills - While oral contraceptive pills may help manage symptoms of leiomyoma, they are not typically used to address infertility issues related to this condition.\n\n2: DMPA (depot medroxyprogesterone acetate) - DMPA is a progestin-only contraceptive injection that is not typically used to address infertility issues related to leiomyoma.\n\n3: GnRH agonist (gonadotropin-releasing hormone agonist) - GnRH agonists are often used to shrink leiomyoma and may be considered in the management of infertility issues associated with this condition.\n\n4: Ulipristal - Ulipristal is a selective progesterone receptor modulator that has been used in the treatment of symptomatic leiomyoma, but its role in addressing infertility issues related to this condition is less clear.\n\nBased on the above information, a medical researcher would likely choose option 3: GnRH agonist as the most appropriate option for addressing infertility issues with leiomyoma.",
    "gpt_response_correct_incorrect": "Yes",
    "attempts": 1,
    "yes_no": "yes",
    "gpt_response_difficulty": "3",
    "difficulty_value": "3"
}